|
How to Cite 1. For In-Text Citation (Materials & Methods): 2. For Key Resources Table: |
||
|
Toll Free: (877) 796-6397 -- USA and Canada only -- |
Fax: +1-832-582-8590 Orders: +1-832-582-8158 |
Tech Support: +1-832-582-8158 Ext:3 Please provide your Order Number in the email. We strive to reply to |
| Formula | C22H25F2NO4 |
||||||||||||||
| Molecular Weight | 405.43 | CAS No. | 118457-14-0 | ||||||||||||
| Solubility (25°C)* | In vitro | DMSO | 88 mg/mL (217.05 mM) | ||||||||||||
| In vivo (Add solvents to the product individually and in order) |
|
||||||||||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. * Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.) |
|||||||||||||||
| Description | Nebivolol (Bystolic,R 065824) is a β1 receptor blocker with nitric oxide-potentiating vasodilatory effect used in treatment of hypertension and also for left ventricular failure. |
|---|
| Therapeutic Effects of Combination of Nebivolol and Donepezil: Targeting Multifactorial Mechanisms in ALS [ Neurotherapeutics, October 2023, 1779-1795] | PubMed: 37782409 |
| Stress and Obesity Signaling Converge on CREB Phosphorylation to Promote Pancreatic Cancer [ Molecular Cancer Research, March 3, 2025, 236-249] | PubMed: 39642318 |
| Nebivolol Inhibits Hepatocellular Carcinoma via RHOQ and Enhances the Efficacy of Lenvatinib [ International Journal of Biological Sciences, March 25, 2026, 3617-3634] | |
| Screening of GPCR drugs for repurposing in breast cancer [ Frontiers in Pharmacology, December 6, 2022, 1049640] | PubMed: 36561339 |
| Adrenergic Blockade by Nebivolol to Suppress Oral Squamous Cell Carcinoma Growth via Endoplasmic Reticulum Stress and Mitochondria Dysfunction [ Frontiers in Pharmacology, August 12, 2021, 691998] | PubMed: 34456721 |
| Integrated screening for small molecules interfering with PKM2: a drug repurposing strategy against glioblastoma [ J Transl Med, 2025, 23(1):1388] | PubMed: 41361767 |
| Masitinib Inhibits Hepatitis A Virus Replication [ Int J Mol Sci, 2023, 24(11)9708] | PubMed: 37298659 |
| Masitinib Inhibits Hepatitis A Virus Replication [ International Journal of Molecular Sciences, 2023, 9708] | PubMed: 37298659 |
| Screening of GPCR drugs for repurposing in breast cancer [ Frontiers in Pharmacology, 2022, 1049640] | PubMed: 36561339 |
| Screening of GPCR drugs for repurposing in breast cancer [ Front Pharmacol, 2022, 13:1049640] | PubMed: 36561339 |
RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.
NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.